Gwendolyn Binder-Scholl
Chief Tech/Sci/R&D Officer at CABALETTA BIO, INC.
Net worth: 203 800 $ as of 30/05/2024
Gwendolyn Binder-Scholl active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CABALETTA BIO, INC. | Chief Tech/Sci/R&D Officer | 31/01/2019 | - |
| INSTIL BIO, INC. | Director/Board Member | 30/06/2020 | - |
| Independent Dir/Board Member | 30/06/2020 | - |
Career history of Gwendolyn Binder-Scholl
Former positions of Gwendolyn Binder-Scholl
| Companies | Position | Start | End |
|---|---|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Chief Tech/Sci/R&D Officer | 31/01/2016 | 30/01/2019 |
| Corporate Officer/Principal | 28/02/2011 | 31/01/2016 | |
| University of Pennsylvania | Corporate Officer/Principal | 31/12/2005 | 31/12/2010 |
VIRxSYS Corp.
 VIRxSYS Corp. BiotechnologyHealth Technology VIRxSYS Corp. is a holding company, which uses its proprietary platform technologies to develop therapies for serious human diseases. Its platform technologies include lentiviral vectors as a delivery vehicle for genes against certain diseases and for vaccine therapies. Its therapies are in various stages of development from pre-clinical through Phase II clinical trials. The company was founded by Boro Dropulic, William J. Turner, and Wiliam N. Sick Jr in 1998 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 31/12/2001 | 31/12/2004 |
Adaptimmune LLC
 Adaptimmune LLC Medical/Nursing ServicesHealth Services Part of Adaptimmune Therapeutics Plc, Adaptimmune LLC is a company that focuses on the use of T cell therapy to treat cancer and infectious disease. The company is based in Philadelphia, PA. | Corporate Officer/Principal | - | - |
Training of Gwendolyn Binder-Scholl
| Wells College | Undergraduate Degree |
| The Johns Hopkins University | Doctorate Degree |
Statistics
International
| United States | 8 |
| United Kingdom | 2 |
Operational
| Corporate Officer/Principal | 4 |
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 4 |
| Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Health Technology |
| CABALETTA BIO, INC. | Health Technology |
| INSTIL BIO, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Adaptimmune LLC
Adaptimmune LLC Medical/Nursing ServicesHealth Services Part of Adaptimmune Therapeutics Plc, Adaptimmune LLC is a company that focuses on the use of T cell therapy to treat cancer and infectious disease. The company is based in Philadelphia, PA. | Health Services |
VIRxSYS Corp.
VIRxSYS Corp. BiotechnologyHealth Technology VIRxSYS Corp. is a holding company, which uses its proprietary platform technologies to develop therapies for serious human diseases. Its platform technologies include lentiviral vectors as a delivery vehicle for genes against certain diseases and for vaccine therapies. Its therapies are in various stages of development from pre-clinical through Phase II clinical trials. The company was founded by Boro Dropulic, William J. Turner, and Wiliam N. Sick Jr in 1998 and is headquartered in Gaithersburg, MD. | Health Technology |
